With aggressive therapy, some of these cats do recover from the poison.
His long term prognosis is guarded; I have had a number of pets with renal failure live several years
with aggressive therapy as was prescribed for Pele.
With aggressive therapy, mortality rates are reduced to 5 - 20 %.
Unlike ER - positive cancers that respond well to treatment, those that are drug - resistant spread elsewhere in the body even
with aggressive therapy.
Estimated mortality rates are 100 % without treatment in young kittens — and even
with aggressive therapies are over 90 %.
Not exact matches
Swiss pharmaceutical giant Novartis has made waves
with a drug pipeline that includes one of the most talked - about experimental cancer
therapies in recent years — a treatment called Kymriah that reconfigures the body's own immune cells to become
aggressive blood - cancer killers.
giant Novartis has made waves
with a drug pipeline that includes one of the most talked - about experimental cancer
therapies in recent years — a treatment called Kymriah that reconfigures the body's own immune cells to become
aggressive blood - cancer killers.
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be used to help identify PSC patients
with a more or less
aggressive disease, or patients that may benefit from microbiota - based
therapies, such as fecal microbiota transplantation or targeted pre - and probiotics.»
In 2014, new combination
therapies to treat patients
with metastatic melanoma hit the market, helping extend the lives of those
with this
aggressive disease.
«This study forms the basis for future research in patients
with breast cancer and offers hope for targeted
therapy for patients
with aggressive triple - negative inflammatory breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.
And it may be possible to enhance the power of talking
therapy with a new computer - based technique designed specifically to combat
aggressive voices, which looks promising from a small pilot study.
Psychological conditions associated
with being unmarried and potentially more
aggressive follow - up and
therapy needs to be considered in future studies.
Cancers
with Ras mutations are
aggressive and respond poorly to standard
therapies.
This is especially concerning because radiation
therapy is increasingly being used after mastectomy as a way to further reduce the risk of the cancer returning in women
with more
aggressive or advanced disease.
Twenty years ago few oncologists would have attempted
aggressive therapies with 90 - year - olds.
A new population - based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone
therapy over a five - year period was not associated
with an increased risk of
aggressive prostate cancer.
It is commonly thought that bladder cancers that develop after pelvic radiation tend to be
aggressive,
with high grades and stages, but this study found that the types, grades, and stages of bladder cancer that developed were similar in patients treated
with and without radiation
therapy.
Chimeric antigen receptor (CAR) T cell
therapy, which edits a cancer patient's T cells to recognize their tumors, has successfully helped patients
with aggressive blood cancers but has yet to show the ability to treat solid tumors.
Oncologists have long known that in rare cases, after patients receive radiation
therapy to shrink a tumor, the immune system will mount an
aggressive response that wipes out not only the tumor, but metastases throughout the body that hadn't been treated
with the radiation.
Since most men
with prostate cancer have indolent (non-
aggressive) disease for which conservative
therapy or surveillance would be appropriate treatment, the clinical challenge is not only how to identify those
with prostate cancer, but also how to distinguish those who would benefit from surgical or other
aggressive treatment from those who would not.
More precise dosing methods and cellular engineering techniques show promise in the effort to improve treatment of
aggressive cancers
with personalized cellular
therapies, according to new studies from researchers in the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania and The Children's Hospital of Philadelphia.
This is the first population - based study to compare the follow - up intensity of American men
with prostate cancer who have not undergone
aggressive treatment
with those who opted to undergo various forms of
aggressive therapy, such as surgery and radiation.
More DMD patients could live longer
with more
aggressive medical
therapy and other treatments, said Dr. Mammen, whose research investigates the molecular mechanisms underlying heart failure.
In the era of personalized cancer
therapy, patients
with TNBC remain at considerably higher risk of relapse and death than patients
with other breast cancer subtypes, due to the
aggressive nature of TNBC and the lack of newer targeted
therapies for the disease.
And while life expectancy has increased
with better
therapies, surgeries, and more
aggressive treatment of identified risk factors, depression has come under increasing scrutiny as a risk factor that could make a difference, if properly treated.
CAR T - cell
therapy shows significant remission rates for those
with aggressive B - cell lymphoma
Scope: 22 institutions Treatment: CD19 - targeting CAR T - cell
therapy Results: 42 % of patients
with aggressive large B - cell lymphoma remained in remission after 15 months
Combination anti — PD - 1 and anti — CTLA - 4 treatment may be the preferred approach in those who are able to tolerate more
aggressive therapies, given the higher response rates observed compared
with single - agent checkpoint blockade.
A small, phase 1 trial, published early online in the journal Radiology, found that this approach, designed to treat just the diseased portion of the prostate rather than removing or irradiating the entire gland, is safe and can be performed without the troubling complications associated
with more
aggressive therapies.
Scientists exploit gene
therapy to shrink tumors in mice
with an
aggressive form of breast cancer.
This gene finding may allow scientists to identify patients
with this
aggressive form of the cancer and target them
with additional
therapies.
Despite
aggressive therapy with surgery, radiation and chemotherapy, long - term survival for HGG patients remains less than 20 percent.
We treat our patients
with the latest scientific advances and develop new, more effective and less
aggressive therapies.
December 13, 2011 Molecular markers can predict spread of cancer, guide treatment Molecular markers found in cancer cells that have spread from a primary tumor to a limited number of distant sites can help physicians predict which patients
with metastatic cancer will benefit from
aggressive, targeted radiation
therapy.
BUFFALO, N.Y. — Although men
with prostate cancer usually respond to standard treatment
with hormone
therapy or chemotherapy, many will eventually experience progression or recurrence despite treatment — particularly those
with high - risk or
aggressive forms of the disease.
In the most
aggressive form of the cancer — grade 4 — patients can live for about a year
with the full complement of
therapies, Subramaniam said.
Sometimes, I had gentle
therapy and other times I had more
aggressive therapy with weights to build up strength; PT helped but the pain always came back.
Dr. Dominic D'Agostino, who researches metabolic
therapy with his team at the University of South Florida, found that when carbohydrates were removed from the diets of lab mice, they survived extremely
aggressive metastatic forms of cancer.
Treatment may include
aggressive fluid
therapy with monitoring urinary output, vasopressors, pain control (
aggressive pain control may be warranted), antioxidants such as N acetylcysteine, diphenhydramine, anti-seizure medications, oxygen, gastroprotectants and transfusions.
Overall, patients tolerate this
therapy well, although this is an
aggressive therapeutic option
with risks from anesthesia, radiation side effects, and infection.
In severe cases of pyometra,
aggressive antibiotic
therapy along
with excellent nursing care (possibly including fluid
therapy) is the best course of action.
An
aggressive strategy to enhance the profile of the shelter, along
with the introduction of community outreach programs — such as the K9 Companion Pet
Therapy Program, which supports volunteer therapeutic visits to hospitals, long - term care homes and seniors» homes — have truly established a new connection to the community.
Treatment for panleukopenia would include
aggressive IV fluid
therapy with crystalloids to replace water and electrolytes, and colloids to compensate for protein loss.
Dog Studies CANCER Novel
Therapies Common heart medications as an effective adjunct
therapy for dogs
with hemangiosarcoma, an
aggressive and deadly cancer.
Despite the severity and scariness of any cancer diagnosis, some dogs
with nasal adenocarcinoma can be well - managed
with timely detection and
aggressive therapy and may live happily for months or even years.
There are several ways to manage pain in our pets from non-invasive
therapy laser (discussed above) to more
aggressive multi-modal
therapies where medications can be combined
with supplements and environmental changes.
Most dogs
with CPV infection recover if
aggressive treatment is used and if
therapy is begun before severe septicemia and dehydration occur.
While digital SCC is typically cured
with surgery alone, digital melanomas are typically more
aggressive requiring both surgery and systemic
therapy to achieve long - term tumor control.
Most of the time bowel obstructions need to be removed through surgery and peritonitis will need to be treated
with aggressive antibiotic
therapy.
Hospitalization is required,
with aggressive IV antibiotics and fluid
therapy.